Evaluation of the Safety and Effectiveness of Aceclidine/Brimonidine (LNZ101) and Aceclidine (LNZ100) in the Treatment of Presbyopia
Clinical trial NCT05294328 · COMPLETED
Trial details
- NCT number
- NCT05294328
- Sponsor
- LENZ Therapeutics, Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-05
- Primary completion
- 2022-08-22
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.